Compass Therapeutics Statistics

Total Valuation

CMPX has a market cap or net worth of $331.36 million. The enterprise value is $136.79 million.

Market Cap	331.36M
Enterprise Value	136.79M

Important Dates

The next estimated earnings date is Wednesday, May 6, 2026, before market open.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

CMPX has 180.09 million shares outstanding. The number of shares has increased by 14.78% in one year.

Current Share Class	180.09M
Shares Outstanding	180.09M
Shares Change (YoY)	+14.78%
Shares Change (QoQ)	+9.52%
Owned by Insiders (%)	8.04%
Owned by Institutions (%)	70.20%
Float	118.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.62
P/TBV Ratio	1.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.02, with a Debt / Equity ratio of 0.05.

Current Ratio	15.02
Quick Ratio	14.96
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.29% and return on invested capital (ROIC) is -26.90%.

Return on Equity (ROE)	-41.29%
Return on Assets (ROA)	-25.29%
Return on Invested Capital (ROIC)	-26.90%
Return on Capital Employed (ROCE)	-35.42%
Weighted Average Cost of Capital (WACC)	11.08%
Revenue Per Employee	n/a
Profits Per Employee	-$1.70M
Employee Count	39
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.15% in the last 52 weeks. The beta is 1.30, so CMPX's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-5.15%
50-Day Moving Average	5.39
200-Day Moving Average	4.62
Relative Strength Index (RSI)	20.33
Average Volume (20 Days)	12,604,695

Short Selling Information

The latest short interest is 26.07 million, so 14.48% of the outstanding shares have been sold short.

Short Interest	26.07M
Short Previous Month	26.13M
Short % of Shares Out	14.48%
Short % of Float	21.93%
Short Ratio (days to cover)	10.58

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-72.84M
Pretax Income	-66.49M
Net Income	-66.49M
EBITDA	-72.56M
EBIT	-72.84M
Earnings Per Share (EPS)	-$0.42

Full Income Statement

Balance Sheet

The company has $208.91 million in cash and $9.83 million in debt, giving a net cash position of $199.08 million or $1.11 per share.

Cash & Cash Equivalents	208.91M
Total Debt	9.83M
Net Cash	199.08M
Net Cash Per Share	$1.11
Equity (Book Value)	196.79M
Book Value Per Share	1.10
Working Capital	195.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$49.14 million and capital expenditures -$25,000, giving a free cash flow of -$49.17 million.

Operating Cash Flow	-49.14M
Capital Expenditures	-25,000
Depreciation & Amortization	276,000
Net Borrowing	n/a
Free Cash Flow	-49.17M
FCF Per Share	-$0.27

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.78%
Shareholder Yield	-14.78%
Earnings Yield	-19.80%
FCF Yield	-14.64%

Analyst Forecast

The average price target for CMPX is $14.57, which is 691.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.57
Price Target Difference	691.85%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2